Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004622 |
---|---|
Receipt number | R000005515 |
Scientific Title | A Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy |
Date of disclosure of the study information | 2011/01/01 |
Last modified on | 2020/01/07 16:17:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/11/25 12:31:59 | ||
2 | Update | 2011/02/01 09:26:56 | Public title Acronym |
|
3 | Update | 2011/02/01 09:34:12 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
4 | Update | 2012/05/30 08:33:46 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2012/05/30 08:34:46 | Recruitment status |
|
6 | Update | 2013/05/25 10:52:47 | Recruitment status |
|
7 | Update | 2014/10/31 14:23:05 | Publication of results Results |
|
8 | Update | 2014/10/31 14:25:04 | Email |
|
9 | Update | 2020/01/07 16:17:11 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |